Key Takeaways Petrobras (PBR) , Brazil's state-controlled oil giant, is evaluating a strategic re-entry into the retail fuel sector as part of its broader plan to combat escalating pump prices and restore consumer trust, according to Bloomberg. This development marks a significant policy shift for the company, which exited the retail business in 2019, divesting its stake in what is now known as Vibra Energia SA. This move, backed by both president Luiz Inacio Lula da Silva and CEO Magda Chambriard, reflects ...

Key Takeaways Morgan Stanley's (MS) second-quarter 2025 earnings per share of $2.13 handily surpassed the Zacks Consensus Estimate of $1.93. The figure also compared favorably with $1.82 per share reported in the prior- year quarter. Additionally, Morgan Stanley's net revenues of $16.79 billion were up 12% from the prior-year quarter and beat the Zacks Consensus Estimate of $15.92 billion. The primary reason for Morgan Stanley's impressive quarterly performance was better-than-expected trading revenues. The ...

Key Takeaways CLB Stock's Trend in Estimate Revision The Zacks Consensus Estimate for second-quarter 2025 earnings has not witnessed any movement in the past seven days. The estimated figure indicates an 18.2% year-over-year decline. The Zacks Consensus Estimate for revenues also indicates a decline of about 1% from the year-ago period's actual. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) Factors to Consider Ahead of CLB's Q2 Release Core Laboratories Inc. (CLB) is set to relea ...

My name is Mike and I'm the author of The Dividend Guy Blog & The Dividend Monk along with the owner and portfolio manager here at Dividend Stocks Rock (DSR). I earned my bachelor degree in finance-marketing, own a CFP title along with an MBA in financial services. Besides being a passionate investor, I'm also happily married with three beautiful children. I started my online venture to educate people about investing and to be able to spend more time with my family. I started my career in the financial indu ...

It's been about a month since my previous coverage on NVIDIA Corporation (NASDAQ: NVDA ), which I upgraded from a sell to a buy, given the value opportunity it presented at its then price of $141. I'm glad I specialize in analyzing individual stocks. With a strong educational background in both finance and economics, I've developed a deep fascination with the stock market and the potential it offers to investors at all levels. I keep a close watch on market trends, particularly in the tech sector. My invest ...

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another. Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a ...

CARMEL, Ind., July 17, 2025 /PRNewswire/ -- Syra Health (OTCQB: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today it has been awarded a new contract with a major insurance provider to staff registered nurses to support specific health plans. Under the one-year agreement, worth up to $2.1 million, Syra Health will provide medical management nurses to work with healthcare providers and plan members. The nurses will a ...

Analyst's Disclosure:I/we have a beneficial long position in the shares of BEP either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any inv ...

Ginkgo Bioworks launches cost-effective, high-throughput ADME profiling service to accelerate small molecule drug discovery with model-ready datasets BOSTON, July 17, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the launch of a powerful new capability at Ginkgo Datapoints: high-throughput, low-cost ADME (Absorption, Distribution, Metabolism, and Excretion) profiling, enabled by Ginkgo's proprietary RAC automati ...

Creating the Leader in Engineering Solutions from Silicon to Systems Synopsys expects to deliver the first set of integrated capabilities in the first half of 2026 that fuse multiphysics across the full EDA stack, including for multi-die advanced packaging. The combined roadmap also includes integrated solutions to advance testing and virtualization of complex, intelligent systems for automotive and other industries. This combination bolsters Synopsys' strong financial position with projected margin expansi ...